Inventor · disambiguated record
Tao Guo
Also filed as: GUO TAO
47 granted patents·7 pending applications·484 citations·filing 1996–2022
98Inventor score
Files withSCHERING CORP10AGIOS PHARMACEUTICALS INC7ZHU ZHAONING6PHARMACOPEIA DRUG DISCOVERY4AHMED GULZAR2
Top patents by PatentIndex Score
54 records- 0197US9512107B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Dec 6, 2016·25 cites·9 claims
- 0296US9656999B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted May 23, 2017·16 cites·4 claims
- 0395US7763609B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2007·Granted Jul 27, 2010·38 cites·12 claims
- 0494US9732062B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2013·Granted Aug 15, 2017·18 cites·6 claims
- 0593US6150527ASynthetic multimerizing agentsARIAD PHARMA INC·Filed 1997·Granted Nov 21, 2000·78 cites·51 claims
- 0692US6133456ASynthetic multimerizing agentsARIAD GENE THERAPEUTICS INC·Filed 1997·Granted Oct 17, 2000·66 cites·8 claims
- 0790US10294215B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Granted May 21, 2019·6 cites·32 claims
- 0890US9243002B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis CMERCK SHARP & DOHME·Filed 2014·Granted Jan 26, 2016·8 cites·17 claims
- 0990US8436183B2Synthetic multimerizing agentsHOLT DENNIS A·Filed 2012·Granted May 7, 2013·6 cites·2 claims
- 1089US8148391B2Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitorsAHMED GULZAR·Filed 2007·Granted Apr 3, 2012·17 cites·8 claims
- 1188US7700603B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2005·Granted Apr 20, 2010·9 cites·8 claims
- 1288US5972719ACombinatorial hydroxy-amino acid amide librariesPHARMACOPEIA INC·Filed 1996·Granted Oct 26, 1999·39 cites·14 claims
- 1387US8106191B2Synthetic multimerizing agentsHOLT DENNIS A·Filed 2003·Granted Jan 31, 2012·17 cites·33 claims
- 1486US11505538B1Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2020·Granted Nov 22, 2022·1 cites·8 claims
- 1586US8829036B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Sep 9, 2014·7 cites·3 claims
- 1686US7973067B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2008·Granted Jul 5, 2011·6 cites·22 claims
- 1785US8691831B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Apr 8, 2014·7 cites·18 claims
- 1885US8691833B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Apr 8, 2014·7 cites·9 claims
- 1985US8552186B2Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitorsAHMED GULZAR·Filed 2012·Granted Oct 8, 2013·10 cites·26 claims
- 2085US8278334B2Cyclic amine BACE-1 inhibitors having a benzamide substituentCUMMING JARED N·Filed 2009·Granted Oct 2, 2012·7 cites·10 claims
- 2184US7592348B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2004·Granted Sep 22, 2009·16 cites·41 claims
- 2283US10017495B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2014·Granted Jul 10, 2018·3 cites·17 claims
- 2382US8513232B2Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligandsBACON EDWARD R·Filed 2010·Granted Aug 20, 2013·9 cites·30 claims
- 2482US2023250078A1Therapeutically active compounds and their methods of useSERVIER PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 2581US7759353B2Substituted spiro iminopyrimidinones as aspartyl protease inhibitors, compositions, and methods of treatmentSCHERING CORP·Filed 2006·Granted Jul 20, 2010·5 cites·14 claims
- 2680US7662816B2Cyclic amine BACE-1 inhibitors having a benzamide substituentSCHERING CORP·Filed 2004·Granted Feb 16, 2010·11 cites·25 claims
- 2779US8871756B2Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus diseaseCHEN LI·Filed 2012·Granted Oct 28, 2014·4 cites·56 claims
- 2877US9725406B1Substituted hydroxystilbenes and their therapeutic applicationsRESOLVEX PHARMACEUTICALS INC·Filed 2016·Granted Aug 8, 2017·3 cites·6 claims
- 2977US8242112B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2011·Granted Aug 14, 2012·2 cites·4 claims
- 3077US6887889B2Aryl and biaryl piperdines with MCH modulatory activityPHARMACOPEIA DRUG DISCOVERY·Filed 2002·Granted May 3, 2005·11 cites·27 claims
- 3175US7256186B2Gamma secretase inhibitorsSCHERING CORP·Filed 2004·Granted Aug 14, 2007·8 cites·24 claims
- 3274US8178513B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2009·Granted May 15, 2012·1 cites·13 claims
- 3372US9062007B2Cyclic amide BACE-1 inhibitors having a benzamide substituentPHARMACOPEIA DRUG DISCOVERY·Filed 2014·Granted Jun 23, 2015·1 cites·6 claims
- 3472US7598250B2Cyclic amine BACE-1 inhibitors having a heterocyclic substituentSCHERING CORP·Filed 2004·Granted Oct 6, 2009·5 cites·34 claims
- 3571US7208602B2Gamma secretase inhibitorsPHARACOPEIA DRUG DISCOVERY INC·Filed 2003·Granted Apr 24, 2007·8 cites·19 claims
- 3670US8722708B2Substituted isoindolines as aspartyl protease inhibitorsSTAMFORD ANDREW·Filed 2006·Granted May 13, 2014·2 cites·9 claims
- 3770US6900213B2Bisaryl derivatives having FSH modulatory activityPHARMACOPEIA DRUG DISCOVERY·Filed 2003·Granted May 31, 2005·5 cites·13 claims
- 3869US8623867B2Cyclic amine BACE-1 inhibitors having a benzamide substituentCUMMING JARED N·Filed 2012·Granted Jan 7, 2014·1 cites·8 claims
- 3969US2020079755A1Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4062US7034056B2Aryl and biaryl compounds having MCH modulatory activityPHARMACOPEIA DRUG DISCOVERY·Filed 2002·Granted Apr 25, 2006·1 cites·26 claims
- 4161USRE49481ECompounds for the treatment and prophylaxis of respiratory syncytial virus diseaseHOFFMANN LA ROCHE·Filed 2020·Granted Apr 4, 2023·0 cites·59 claims
- 4261US8778980B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Jul 15, 2014·0 cites·15 claims
- 4352US8937093B2Heterocyclic aspartyl protease inhibitorsSAIONZ KURT W·Filed 2012·Granted Jan 20, 2015·0 cites·4 claims
- 4451US2006100427A1Novel Gamma Secretase inhibitorsSCHERING CORP AND PHARMACOPEIA·Filed 2005·Application pending·0 cites
- 4549US10166201B2Substituted hydroxystilbenes and their therapeutic applicationsRESOLVEX PHARMACEUTICALS INC·Filed 2017·Granted Jan 1, 2019·0 cites·12 claims
- 4648US2021260091A1Use of salidroside and derivative thereof in preparation of inhibitor medicament for diseases of ophthalmic fibrosis caused by abnormalities of extracellular matrix proteinsSHANGHAI NINTH PEOPLES HOSPITAL SHANGHAIJIAOTONG UNIV SCHOOL OF MEDICINE·Filed 2019·Application pending·0 cites
- 4748US2003036654A1Synthetic multimerizing agentsFiled 2002·Application pending·0 cites
- 4846US7511146B22-substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disordersSCHERING CORP·Filed 2004·Granted Mar 31, 2009·0 cites·13 claims
- 4945US2004171614A1Novel gamma secretase inhibitorsSCHERING PLOUGH CORP·Filed 2003·Application pending·0 cites
- 5043US7550467B2Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disordersSCHERING CORP·Filed 2005·Granted Jun 23, 2009·0 cites·19 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Tao Guo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →